Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antiserum Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Antitoxin Serum
1.2.3 Antibacterial Serum
1.2.4 Antiviral Serum
1.2.5 Others
1.3 Market by Application
1.3.1 Global Antiserum Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Clinical
1.3.3 Laboratory
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antiserum Market Perspective (2018-2029)
2.2 Antiserum Growth Trends by Region
2.2.1 Global Antiserum Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Antiserum Historic Market Size by Region (2018-2024)
2.2.3 Antiserum Forecasted Market Size by Region (2024-2029)
2.3 Antiserum Market Dynamics
2.3.1 Antiserum Industry Trends
2.3.2 Antiserum Market Drivers
2.3.3 Antiserum Market Challenges
2.3.4 Antiserum Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antiserum Players by Revenue
3.1.1 Global Top Antiserum Players by Revenue (2018-2024)
3.1.2 Global Antiserum Revenue Market Share by Players (2018-2024)
3.2 Global Antiserum Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antiserum Revenue
3.4 Global Antiserum Market Concentration Ratio
3.4.1 Global Antiserum Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antiserum Revenue in 2022
3.5 Antiserum Key Players Head office and Area Served
3.6 Key Players Antiserum Product Solution and Service
3.7 Date of Enter into Antiserum Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antiserum Breakdown Data by Type
4.1 Global Antiserum Historic Market Size by Type (2018-2024)
4.2 Global Antiserum Forecasted Market Size by Type (2024-2029)
5 Antiserum Breakdown Data by Application
5.1 Global Antiserum Historic Market Size by Application (2018-2024)
5.2 Global Antiserum Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Antiserum Market Size (2018-2029)
6.2 North America Antiserum Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Antiserum Market Size by Country (2018-2024)
6.4 North America Antiserum Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antiserum Market Size (2018-2029)
7.2 Europe Antiserum Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Antiserum Market Size by Country (2018-2024)
7.4 Europe Antiserum Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antiserum Market Size (2018-2029)
8.2 Asia-Pacific Antiserum Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Antiserum Market Size by Region (2018-2024)
8.4 Asia-Pacific Antiserum Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antiserum Market Size (2018-2029)
9.2 Latin America Antiserum Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Antiserum Market Size by Country (2018-2024)
9.4 Latin America Antiserum Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antiserum Market Size (2018-2029)
10.2 Middle East & Africa Antiserum Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Antiserum Market Size by Country (2018-2024)
10.4 Middle East & Africa Antiserum Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BD
11.1.1 BD Company Detail
11.1.2 BD Business Overview
11.1.3 BD Antiserum Introduction
11.1.4 BD Revenue in Antiserum Business (2018-2024)
11.1.5 BD Recent Development
11.2 Bio-Rad
11.2.1 Bio-Rad Company Detail
11.2.2 Bio-Rad Business Overview
11.2.3 Bio-Rad Antiserum Introduction
11.2.4 Bio-Rad Revenue in Antiserum Business (2018-2024)
11.2.5 Bio-Rad Recent Development
11.3 Shanghai Serum Bio-Technology Co., Ltd.
11.3.1 Shanghai Serum Bio-Technology Co., Ltd. Company Detail
11.3.2 Shanghai Serum Bio-Technology Co., Ltd. Business Overview
11.3.3 Shanghai Serum Bio-Technology Co., Ltd. Antiserum Introduction
11.3.4 Shanghai Serum Bio-Technology Co., Ltd. Revenue in Antiserum Business (2018-2024)
11.3.5 Shanghai Serum Bio-Technology Co., Ltd. Recent Development
11.4 China National Pharmaceutical Group
11.4.1 China National Pharmaceutical Group Company Detail
11.4.2 China National Pharmaceutical Group Business Overview
11.4.3 China National Pharmaceutical Group Antiserum Introduction
11.4.4 China National Pharmaceutical Group Revenue in Antiserum Business (2018-2024)
11.4.5 China National Pharmaceutical Group Recent Development
11.5 CSL
11.5.1 CSL Company Detail
11.5.2 CSL Business Overview
11.5.3 CSL Antiserum Introduction
11.5.4 CSL Revenue in Antiserum Business (2018-2024)
11.5.5 CSL Recent Development
11.6 Merck
11.6.1 Merck Company Detail
11.6.2 Merck Business Overview
11.6.3 Merck Antiserum Introduction
11.6.4 Merck Revenue in Antiserum Business (2018-2024)
11.6.5 Merck Recent Development
11.7 BTG
11.7.1 BTG Company Detail
11.7.2 BTG Business Overview
11.7.3 BTG Antiserum Introduction
11.7.4 BTG Revenue in Antiserum Business (2018-2024)
11.7.5 BTG Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Detail
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Antiserum Introduction
11.8.4 Pfizer Revenue in Antiserum Business (2018-2024)
11.8.5 Pfizer Recent Development
11.9 Haffkine Bio-Pharmaceutical
11.9.1 Haffkine Bio-Pharmaceutical Company Detail
11.9.2 Haffkine Bio-Pharmaceutical Business Overview
11.9.3 Haffkine Bio-Pharmaceutical Antiserum Introduction
11.9.4 Haffkine Bio-Pharmaceutical Revenue in Antiserum Business (2018-2024)
11.9.5 Haffkine Bio-Pharmaceutical Recent Development
11.10 Vins Bioproducts
11.10.1 Vins Bioproducts Company Detail
11.10.2 Vins Bioproducts Business Overview
11.10.3 Vins Bioproducts Antiserum Introduction
11.10.4 Vins Bioproducts Revenue in Antiserum Business (2018-2024)
11.10.5 Vins Bioproducts Recent Development
11.11 Bharat Serums and Vaccines
11.11.1 Bharat Serums and Vaccines Company Detail
11.11.2 Bharat Serums and Vaccines Business Overview
11.11.3 Bharat Serums and Vaccines Antiserum Introduction
11.11.4 Bharat Serums and Vaccines Revenue in Antiserum Business (2018-2024)
11.11.5 Bharat Serums and Vaccines Recent Development
11.12 SSI Diagnostica
11.12.1 SSI Diagnostica Company Detail
11.12.2 SSI Diagnostica Business Overview
11.12.3 SSI Diagnostica Antiserum Introduction
11.12.4 SSI Diagnostica Revenue in Antiserum Business (2018-2024)
11.12.5 SSI Diagnostica Recent Development
11.13 GD Animal Health
11.13.1 GD Animal Health Company Detail
11.13.2 GD Animal Health Business Overview
11.13.3 GD Animal Health Antiserum Introduction
11.13.4 GD Animal Health Revenue in Antiserum Business (2018-2024)
11.13.5 GD Animal Health Recent Development
11.14 MicroPharm
11.14.1 MicroPharm Company Detail
11.14.2 MicroPharm Business Overview
11.14.3 MicroPharm Antiserum Introduction
11.14.4 MicroPharm Revenue in Antiserum Business (2018-2024)
11.14.5 MicroPharm Recent Development
11.15 Peptide Institute Inc.
11.15.1 Peptide Institute Inc. Company Detail
11.15.2 Peptide Institute Inc. Business Overview
11.15.3 Peptide Institute Inc. Antiserum Introduction
11.15.4 Peptide Institute Inc. Revenue in Antiserum Business (2018-2024)
11.15.5 Peptide Institute Inc. Recent Development
11.16 Rare Disease Therapeutics
11.16.1 Rare Disease Therapeutics Company Detail
11.16.2 Rare Disease Therapeutics Business Overview
11.16.3 Rare Disease Therapeutics Antiserum Introduction
11.16.4 Rare Disease Therapeutics Revenue in Antiserum Business (2018-2024)
11.16.5 Rare Disease Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Antiserum Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Antitoxin Serum
Table 3. Key Players of Antibacterial Serum
Table 4. Key Players of Antiviral Serum
Table 5. Key Players of Others
Table 6. Global Antiserum Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Antiserum Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Antiserum Market Size by Region (2018-2024) & (US$ Million)
Table 9. Global Antiserum Market Share by Region (2018-2024)
Table 10. Global Antiserum Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Antiserum Market Share by Region (2024-2029)
Table 12. Antiserum Market Trends
Table 13. Antiserum Market Drivers
Table 14. Antiserum Market Challenges
Table 15. Antiserum Market Restraints
Table 16. Global Antiserum Revenue by Players (2018-2024) & (US$ Million)
Table 17. Global Antiserum Market Share by Players (2018-2024)
Table 18. Global Top Antiserum Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiserum as of 2022)
Table 19. Ranking of Global Top Antiserum Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Antiserum Revenue (CR5 and HHI) & (2018-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Antiserum Product Solution and Service
Table 23. Date of Enter into Antiserum Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Antiserum Market Size by Type (2018-2024) & (US$ Million)
Table 26. Global Antiserum Revenue Market Share by Type (2018-2024)
Table 27. Global Antiserum Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Antiserum Revenue Market Share by Type (2024-2029)
Table 29. Global Antiserum Market Size by Application (2018-2024) & (US$ Million)
Table 30. Global Antiserum Revenue Market Share by Application (2018-2024)
Table 31. Global Antiserum Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Antiserum Revenue Market Share by Application (2024-2029)
Table 33. North America Antiserum Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Antiserum Market Size by Country (2018-2024) & (US$ Million)
Table 35. North America Antiserum Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Antiserum Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Antiserum Market Size by Country (2018-2024) & (US$ Million)
Table 38. Europe Antiserum Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Antiserum Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Antiserum Market Size by Region (2018-2024) & (US$ Million)
Table 41. Asia-Pacific Antiserum Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Antiserum Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Antiserum Market Size by Country (2018-2024) & (US$ Million)
Table 44. Latin America Antiserum Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Antiserum Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Antiserum Market Size by Country (2018-2024) & (US$ Million)
Table 47. Middle East & Africa Antiserum Market Size by Country (2024-2029) & (US$ Million)
Table 48. BD Company Detail
Table 49. BD Business Overview
Table 50. BD Antiserum Product
Table 51. BD Revenue in Antiserum Business (2018-2024) & (US$ Million)
Table 52. BD Recent Development
Table 53. Bio-Rad Company Detail
Table 54. Bio-Rad Business Overview
Table 55. Bio-Rad Antiserum Product
Table 56. Bio-Rad Revenue in Antiserum Business (2018-2024) & (US$ Million)
Table 57. Bio-Rad Recent Development
Table 58. Shanghai Serum Bio-Technology Co., Ltd. Company Detail
Table 59. Shanghai Serum Bio-Technology Co., Ltd. Business Overview
Table 60. Shanghai Serum Bio-Technology Co., Ltd. Antiserum Product
Table 61. Shanghai Serum Bio-Technology Co., Ltd. Revenue in Antiserum Business (2018-2024) & (US$ Million)
Table 62. Shanghai Serum Bio-Technology Co., Ltd. Recent Development
Table 63. China National Pharmaceutical Group Company Detail
Table 64. China National Pharmaceutical Group Business Overview
Table 65. China National Pharmaceutical Group Antiserum Product
Table 66. China National Pharmaceutical Group Revenue in Antiserum Business (2018-2024) & (US$ Million)
Table 67. China National Pharmaceutical Group Recent Development
Table 68. CSL Company Detail
Table 69. CSL Business Overview
Table 70. CSL Antiserum Product
Table 71. CSL Revenue in Antiserum Business (2018-2024) & (US$ Million)
Table 72. CSL Recent Development
Table 73. Merck Company Detail
Table 74. Merck Business Overview
Table 75. Merck Antiserum Product
Table 76. Merck Revenue in Antiserum Business (2018-2024) & (US$ Million)
Table 77. Merck Recent Development
Table 78. BTG Company Detail
Table 79. BTG Business Overview
Table 80. BTG Antiserum Product
Table 81. BTG Revenue in Antiserum Business (2018-2024) & (US$ Million)
Table 82. BTG Recent Development
Table 83. Pfizer Company Detail
Table 84. Pfizer Business Overview
Table 85. Pfizer Antiserum Product
Table 86. Pfizer Revenue in Antiserum Business (2018-2024) & (US$ Million)
Table 87. Pfizer Recent Development
Table 88. Haffkine Bio-Pharmaceutical Company Detail
Table 89. Haffkine Bio-Pharmaceutical Business Overview
Table 90. Haffkine Bio-Pharmaceutical Antiserum Product
Table 91. Haffkine Bio-Pharmaceutical Revenue in Antiserum Business (2018-2024) & (US$ Million)
Table 92. Haffkine Bio-Pharmaceutical Recent Development
Table 93. Vins Bioproducts Company Detail
Table 94. Vins Bioproducts Business Overview
Table 95. Vins Bioproducts Antiserum Product
Table 96. Vins Bioproducts Revenue in Antiserum Business (2018-2024) & (US$ Million)
Table 97. Vins Bioproducts Recent Development
Table 98. Bharat Serums and Vaccines Company Detail
Table 99. Bharat Serums and Vaccines Business Overview
Table 100. Bharat Serums and Vaccines Antiserum Product
Table 101. Bharat Serums and Vaccines Revenue in Antiserum Business (2018-2024) & (US$ Million)
Table 102. Bharat Serums and Vaccines Recent Development
Table 103. SSI Diagnostica Company Detail
Table 104. SSI Diagnostica Business Overview
Table 105. SSI Diagnostica Antiserum Product
Table 106. SSI Diagnostica Revenue in Antiserum Business (2018-2024) & (US$ Million)
Table 107. SSI Diagnostica Recent Development
Table 108. GD Animal Health Company Detail
Table 109. GD Animal Health Business Overview
Table 110. GD Animal Health Antiserum Product
Table 111. GD Animal Health Revenue in Antiserum Business (2018-2024) & (US$ Million)
Table 112. GD Animal Health Recent Development
Table 113. MicroPharm Company Detail
Table 114. MicroPharm Business Overview
Table 115. MicroPharm Antiserum Product
Table 116. MicroPharm Revenue in Antiserum Business (2018-2024) & (US$ Million)
Table 117. MicroPharm Recent Development
Table 118. Peptide Institute Inc. Company Detail
Table 119. Peptide Institute Inc. Business Overview
Table 120. Peptide Institute Inc. Antiserum Product
Table 121. Peptide Institute Inc. Revenue in Antiserum Business (2018-2024) & (US$ Million)
Table 122. Peptide Institute Inc. Recent Development
Table 123. Rare Disease Therapeutics Company Detail
Table 124. Rare Disease Therapeutics Business Overview
Table 125. Rare Disease Therapeutics Antiserum Product
Table 126. Rare Disease Therapeutics Revenue in Antiserum Business (2018-2024) & (US$ Million)
Table 127. Rare Disease Therapeutics Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antiserum Market Size Comparison by Type (2024-2029) & (US$ Million)
Figure 2. Global Antiserum Market Share by Type: 2022 VS 2029
Figure 3. Antitoxin Serum Features
Figure 4. Antibacterial Serum Features
Figure 5. Antiviral Serum Features
Figure 6. Others Features
Figure 7. Global Antiserum Market Size Comparison by Application (2024-2029) & (US$ Million)
Figure 8. Global Antiserum Market Share by Application: 2022 VS 2029
Figure 9. Clinical Case Studies
Figure 10. Laboratory Case Studies
Figure 11. Antiserum Report Years Considered
Figure 12. Global Antiserum Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Antiserum Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Antiserum Market Share by Region: 2022 VS 2029
Figure 15. Global Antiserum Market Share by Players in 2022
Figure 16. Global Top Antiserum Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiserum as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Antiserum Revenue in 2022
Figure 18. North America Antiserum Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Antiserum Market Share by Country (2018-2029)
Figure 20. United States Antiserum Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Antiserum Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Antiserum Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Antiserum Market Share by Country (2018-2029)
Figure 24. Germany Antiserum Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Antiserum Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Antiserum Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Antiserum Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Antiserum Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Antiserum Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Antiserum Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Antiserum Market Share by Region (2018-2029)
Figure 32. China Antiserum Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Antiserum Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Antiserum Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Antiserum Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Antiserum Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Antiserum Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Antiserum Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Antiserum Market Share by Country (2018-2029)
Figure 40. Mexico Antiserum Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Antiserum Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Antiserum Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Antiserum Market Share by Country (2018-2029)
Figure 44. Turkey Antiserum Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Antiserum Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. BD Revenue Growth Rate in Antiserum Business (2018-2024)
Figure 47. Bio-Rad Revenue Growth Rate in Antiserum Business (2018-2024)
Figure 48. Shanghai Serum Bio-Technology Co., Ltd. Revenue Growth Rate in Antiserum Business (2018-2024)
Figure 49. China National Pharmaceutical Group Revenue Growth Rate in Antiserum Business (2018-2024)
Figure 50. CSL Revenue Growth Rate in Antiserum Business (2018-2024)
Figure 51. Merck Revenue Growth Rate in Antiserum Business (2018-2024)
Figure 52. BTG Revenue Growth Rate in Antiserum Business (2018-2024)
Figure 53. Pfizer Revenue Growth Rate in Antiserum Business (2018-2024)
Figure 54. Haffkine Bio-Pharmaceutical Revenue Growth Rate in Antiserum Business (2018-2024)
Figure 55. Vins Bioproducts Revenue Growth Rate in Antiserum Business (2018-2024)
Figure 56. Bharat Serums and Vaccines Revenue Growth Rate in Antiserum Business (2018-2024)
Figure 57. SSI Diagnostica Revenue Growth Rate in Antiserum Business (2018-2024)
Figure 58. GD Animal Health Revenue Growth Rate in Antiserum Business (2018-2024)
Figure 59. MicroPharm Revenue Growth Rate in Antiserum Business (2018-2024)
Figure 60. Peptide Institute Inc. Revenue Growth Rate in Antiserum Business (2018-2024)
Figure 61. Rare Disease Therapeutics Revenue Growth Rate in Antiserum Business (2018-2024)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed